These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 31504503)

  • 1. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis.
    Guerrero EN; Mitra J; Wang H; Rangaswamy S; Hegde PM; Basu P; Rao KS; Hegde ML
    Hum Mol Genet; 2019 Sep; 28(18):3161-3162. PubMed ID: 31504503
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis.
    Guerrero EN; Mitra J; Wang H; Rangaswamy S; Hegde PM; Basu P; Rao KS; Hegde ML
    Hum Mol Genet; 2019 Aug; 28(15):2459-2476. PubMed ID: 31067307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
    Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
    FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS.
    Dong H; Xu L; Wu L; Wang X; Duan W; Li H; Li C
    Neuroscience; 2014 Jul; 272():141-53. PubMed ID: 24785678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro.
    Penndorf D; Tadić V; Witte OW; Grosskreutz J; Kretz A
    PLoS One; 2017; 12(8):e0183684. PubMed ID: 28832631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
    MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.
    Berg E; Christensen MO; Dalla Rosa I; Wannagat E; Jänicke RU; Rösner LM; Dirks WG; Boege F; Mielke C
    DNA Repair (Amst); 2011 Dec; 10(12):1232-42. PubMed ID: 21982441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo.
    Choksi DK; Roy B; Chatterjee S; Yusuff T; Bakhoum MF; Sengupta U; Ambegaokar S; Kayed R; Jackson GR
    Hum Mol Genet; 2014 Feb; 23(4):1025-35. PubMed ID: 24105464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
    Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
    J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.
    Wang X; Ma M; Teng J; Che X; Zhang W; Feng S; Zhou S; Zhang Y; Wu E; Ding X
    Int J Biol Sci; 2015; 11(7):752-61. PubMed ID: 26078717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity.
    Suzuki H; Matsuoka M
    J Neurochem; 2011 Dec; 119(5):1099-107. PubMed ID: 21933185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione monoethyl ester prevents TDP-43 pathology in motor neuronal NSC-34 cells.
    Chen T; Turner BJ; Beart PM; Sheehan-Hennessy L; Elekwachi C; Muyderman H
    Neurochem Int; 2018 Jan; 112():278-287. PubMed ID: 28818672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells.
    Grawunder U; Wilm M; Wu X; Kulesza P; Wilson TE; Mann M; Lieber MR
    Nature; 1997 Jul; 388(6641):492-5. PubMed ID: 9242410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.
    Cykowski MD; Takei H; Schulz PE; Appel SH; Powell SZ
    Acta Neuropathol Commun; 2014 Dec; 2():171. PubMed ID: 25539830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
    Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
    Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.